本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cullinan Therapeutics

7.83
+0.43005.81%
盘后7.960.1300+1.66%18:17 EDT
成交量:187.08万
成交额:1,456.10万
市值:4.63亿
市盈率:-2.22
高:8.02
开:7.67
低:7.37
收:7.40
52周最高:17.98
52周最低:5.68
股本:5,907.44万
流通股本:3,605.51万
量比:0.80
换手率:5.19%
股息:- -
股息率:- -
每股收益(TTM):-3.5202
每股收益(LYR):-3.1129
净资产收益率:-36.01%
总资产收益率:-24.42%
市净率:0.94
市盈率(LYR):-2.52

数据加载中...

公司资料

公司名字:
Cullinan Therapeutics
交易所:
NASDAQ
成立时间:
2016
员工人数:
111
公司地址:
One Main Street,Suite 1350,Cambridge,Massachusetts,United States
邮编:
02142
电话:
传真:
- -
简介:
Cullinan Therapeutics, Inc.于特拉华州注册成立。该公司是一家生物制药公司,专注于为癌症患者开发具有转化潜力的肿瘤靶向治疗和免疫肿瘤治疗的多样化渠道。

董事

名称
职位
Anthony Rosenberg
Chairman of the Board
Nadim Ahmed
Director, President and Chief Executive Officer
David D. Meek
Independent Director
Mary T. Thistle
Independent Director
Stephen Webster
Independent Director
Andrew Allen
Director
Mittie Doyle
Director

股东

名称
职位
Nadim Ahmed
Director, President and Chief Executive Officer
Mary Kay Fenton
Chief Financial Officer and Principal Accounting Officer
Corinne Savill
Chief Business Officer
Jacquelyn Sumer, Esq
Chief Legal Officer, Chief Compliance Officer and Secretary
Jeffrey Jones
Chief Medical Officer
Jennifer Michaelson
Chief Scientific Officer